Pacific Biosciences's total assets for Q3 2025 were $803.16M, a decrease of -2.70% from the previous quarter. PACB total liabilities were $767.07M for the fiscal quarter, a 0.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.